Literature DB >> 2908447

Expression of the Alzheimer amyloid precursor gene transcripts in the human brain.

R L Neve1, E A Finch, L R Dawes.   

Abstract

An alternate form of the Alzheimer amyloid protein precursor mRNA that encodes a protease inhibitor domain has recently been reported. Oligonucleotide probes that differentiate between the two mRNAs are used to describe the expression of each amyloid precursor transcript in the human brain. RNA blot analyses show that one of the mRNAs is expressed selectively in the nervous system, that the two messages display different regional distributions in the adult human brain, and that the expression of the two mRNAs is differentially affected in Down's syndrome brain and in Alzheimer's disease frontal cortex. In situ hybridization shows that the two transcripts display the same laminar distribution in the adult cortex but that the transcripts differ significantly in their levels of expression in pyramidal cells of the hippocampus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2908447     DOI: 10.1016/0896-6273(88)90166-3

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  61 in total

1.  Differential effect of zinc finger deletions on the binding of CTCF to the promoter of the amyloid precursor protein gene.

Authors:  W W Quitschke; M J Taheny; L J Fochtmann; A A Vostrov
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

2.  Inhibition of the NGF and IL-1beta-induced expression of Alzheimer's amyloid precursor protein by antisense oligonucleotides.

Authors:  K A Chang; S H Kim; Y Sakaki; H S Kim; C W Park; Y H Suh
Journal:  J Mol Neurosci       Date:  1999-02       Impact factor: 3.444

3.  Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA.

Authors:  J M Pasternack; C R Abraham; B J Van Dyke; H Potter; S G Younkin
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

4.  Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study.

Authors:  H Yamaguchi; T Yamazaki; C A Lemere; M P Frosch; D J Selkoe
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

5.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.

Authors:  E H Koo; S S Sisodia; D R Archer; L J Martin; A Weidemann; K Beyreuther; P Fischer; C L Masters; D L Price
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 6.  Review and hypothesis: Alzheimer disease and Down syndrome--chromosome 21 nondisjunction may underlie both disorders.

Authors:  H Potter
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

7.  Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis.

Authors:  S Bursztajn; R DeSouza; D L McPhie; S A Berman; J Shioi; N K Robakis; R L Neve
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

8.  Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path.

Authors:  J D Buxbaum; G Thinakaran; V Koliatsos; J O'Callahan; H H Slunt; D L Price; S S Sisodia
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751.

Authors:  L S Higgins; J M Rodems; R Catalano; D Quon; B Cordell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer's disease-causing dominant mutation APPsw.

Authors:  Peter M Kragh; Anders Lade Nielsen; Juan Li; Yutao Du; Lin Lin; Mette Schmidt; Ingrid Brück Bøgh; Ida E Holm; Jannik E Jakobsen; Marianne G Johansen; Stig Purup; Lars Bolund; Gábor Vajta; Arne Lund Jørgensen
Journal:  Transgenic Res       Date:  2009-01-29       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.